Quinazolinone derivatives
AssigneeSumitomo Pharmaceuticals Company, Limited
InventorsMasami Muraoka, Kazuki Matsui, Koji Morishita, Naohito Ohashi
Life of this patent
Estimating the term…
Loading patent…
AssigneeSumitomo Pharmaceuticals Company, Limited
InventorsMasami Muraoka, Kazuki Matsui, Koji Morishita, Naohito Ohashi
Estimating the term…
A compound given by general formula (1): [wherein T represents oxygen or sulfur atom, Y represents alkyl, cycloalkyl group, etc., ring W represents benzene ring, etc., R1 and R2 represent independently hydrogen atom, lower alkyl group, etc., and R3 represents hydrogen atom, alkyl group, etc. Z represents a group given by formula: {wherein A1 and A2 represent independently hydrogen atom, alkyl group, etc. and G represents straight chain alkylene having 1-6 of the carbon number, etc.} or a group given by formula: {wherein n represents 0, 1 or 2, ring E represents 4-8 membered saturated heterocyclic ring containing nitrogen atom(s), and A3 represents hydrogen atom, alkyl group, etc.}], its prodrug or pharmaceutically acceptable salt thereof is an antagonist against muscarinic receptor that is useful as anticholinergic medicaments, and therefore it is useful as pollakiuria or urinary incontinence remedy.
A method for treating urinary incontinence or pollakiuria, which comprises administering a compound given by general formula (1):
Dependencies are inferred from the claim text.